Sensydia Appoints Rusty Page as President & COO

Sensydia, a company specializing in non-invasive cardiac assessment, has named Rusty Page as its new president and chief operating officer (COO).

Page joined Sensydia from Neuronetics, where he was SVP, chief information and operations officer. He boasts over 20 years of senior leadership experience in the medical device and diagnostics industry.

He previously held multiple executive roles in the industry, including VP of operations and quality and GM at Bioness, where he was a founding team member. He helped lead the company through growth, product launches, and its acquisition by Bioventus in 2021.

“Rusty’s track record guiding early-stage medical device companies from development through product launch and commercialization makes him an ideal addition to Sensydia’s leadership team,” said Anthony Arnold, CEO of Sensydia. “His operational and strategic expertise will be instrumental as we scale for growth and take CPS to the market.”

In March 2024, the company completed its 50-subject development study at the University of Minnesota (UMN). The company conducted the study to collect data for its AI-powered, non-invasive Cardiac Performance System (CPS), which uses heart sound analysis to help clinicians detect heart failure and pulmonary hypertension earlier and treat the conditions more effectively.

“I’m thrilled to join Sensydia at such a pivotal time in the company’s journey,” said Page. “The potential of the Cardiac Performance System to transform cardiovascular care is truly exciting, and I look forward to helping scale Sensydia’s operations and to support its path toward commercialization.”